Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 5, 2010, Pages 995-1001

  Dong, Ming Qing ^a   Sun, Hai Ying ^a   Tang, Qiang ^a   Tse, Hung Fat ^a   Lau, Chu Pak ^a   Li, Gui Rong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Electrophysiology; Epidermal growth factor receptor kinase; Protein tyrosine phosphorylation; Recombinant cardiac hKCNQ1 hKCNE1 channel

Indexed keywords

DAIDZEIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GENISTEIN; ORTHOVANADIC ACID; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; TYRPHOSTIN;

ARTICLE; CELL STRAIN HEK293; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; CELL LINE; ELECTROPHYSIOLOGY; GENISTEIN; HUMANS; ION CHANNEL GATING; KCNQ1 POTASSIUM CHANNEL; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SRC-FAMILY KINASES; TYROSINE; TYRPHOSTINS; VANADATES;

EID: 77949263580     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.01.010     Document Type: Article

References (38)

1. Hunter T. Signaling-2000 and beyond. Cell 100 (2000) 113-127
2. Davis M.J., Wu X., Nurkiewicz T.R., Kawasaki J., Gui P., Hill M.A., and Wilson E. Regulation of ion channels by protein tyrosine phosphorylation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1835-H1862
3. 2+ current in guinea pig ventricular myocytes treated with modulators of tyrosine phosphorylation. Am. J. Physiol. 276 (1999) H1724-H1733
4. Liu H., Li K., and Sperelakis N. Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells. Can. J. Physiol. Pharmacol. 75 (1997) 1058-1062
5. Cataldi M., Taglialatela M., Guerriero S., Amoroso S., Lombardi G., di Renzo G., and Annunziato L. Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. J. Biol. Chem. 271 (1996) 9441-9446
6. Sorota S. Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current. Pflugers Arch. 431 (1995) 178-185
7. Du X.L., Gao Z., Lau C.P., Chiu S.W., Tse H.F., Baumgarten C.M., and Li G.R. Differential effects of tyrosine kinase inhibitors on volume-sensitive chloride current in human atrial myocytes: evidence for dual regulation by Src and EGFR kinases. J. Gen. Physiol. 123 (2004) 427-439
8. Ahern C.A., Zhang J.F., Wookalis M.J., and Horn R. Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ. Res. 96 (2005) 991-998
9. Liu H., Sun H.Y., Lau C.P., and Li G.R. Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J. Mol. Cell. Cardiol. 42 (2007) 760-768
10. Tokuda S., Niisato N., Morisaki S., and Marunaka Y. Calmodulin-dependent regulation of hypotonicity-induced translocation of ENaC in renal epithelial A6 cells. Biochem. Biophys. Res. Commun. 298 (2002) 619-623
11. + channel gating in mouse Schwann cells. J. Physiol. 519 Pt 2 (1999) 373-384
12. Gao Z., Lau C.P., Wong T.M., and Li G.R. Protein tyrosine kinase-dependent modulation of voltage-dependent potassium channels by genistein in rat cardiac ventricular myocytes. Cell. Signal. 16 (2004) 333-341
13. Li Y., Langlais P., Gamper N., Liu F., and Shapiro M.S. Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase. J. Biol. Chem. 279 (2004) 45399-45407
14. Zhang D.Y., Wang Y., Lau C.P., Tse H.F., and Li G.R. Both EGFR kinase and Src-related tyrosine kinases regulate human ether-a-go-go-related gene potassium channels. Cell. Signal. 20 (2008) 1815-1821
15. Zhou Y.Y., Yao J.A., and Tseng G.N. Role of tyrosine kinase activity in cardiac slow delayed rectifier channel modulation by cell swelling. Pflugers Arch. 433 (1997) 750-757
16. Washizuka T., Horie M., Obayashi K., and Sasayama S. Genistein inhibits slow component delayed-rectifier K currents via a tyrosine kinase-independent pathway. J. Mol. Cell. Cardiol. 30 (1998) 2577-2590
17. + current in guinea-pig ventricular myocytes. J. Physiol. 573 (2006) 469-482
18. Missan S., Qi J., Crack J., McDonald T.F., and Linsdell P. Regulation of wild-type and mutant KCNQ1/KCNE1 channels by tyrosine kinase. Pflugers Arch. 458 (2009) 471-480
19. Dong M.Q., Lau C.P., Gao Z., Tseng G.N., and Li G.R. Characterization of recombinant human cardiac KCNQ1/KCNE1 channels (I(Ks)) stably expressed in HEK 293 cells. J. Membr. Biol. 210 (2006) 183-192
20. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., and Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271 (1996) 695-701
21. Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S., Atkinson D.L., and Keating M.T. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384 (1996) 80-83
22. + current in human ventricular myocytes. Circ. Res. 78 (1996) 689-696
23. + current by protein kinase C and protein kinase A. Circ. Res. 83 (1998) 995-1002
24. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., and Kass R.S. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295 (2002) 496-499
25. Ks channel complex inhibits drug block: novel mechanism underlying variable antiarrhythmic drug actions. Circulation 108 (2003) 132-134
26. Ks potassium current by membrane phosphatidylinositol 4, 5-bisphosphate. J. Biol. Chem. 279 (2004) 50726-50734
27. Park K.H., Piron J., Dahimene S., Merot J., Baro I., Escande D., and Loussouarn G. Impaired KCNQ1-KCNE1 and phosphatidylinositol-4, 5-bisphosphate interaction underlies the long QT syndrome. Circ. Res. 96 (2005) 730-739
28. + channels. EMBO J. 22 (2003) 5412-5421
29. Ks channel gating and assembly: impaired function in long-QT mutations. Circ. Res. 98 (2006) 1055-1063
30. Missan S., Linsdell P., and McDonald T.F. Involvement of tyrosine kinase in the hyposmotic stimulation of I(Ks) in guinea-pig ventricular myocytes. Pflugers Arch. 456 (2008) 489-500
31. Kramer H.K., Onoprishvili I., Andria M.L., Hanna K., Sheinkman K., Haddad L.B., and Simon E.J. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacol. 2 (2002) 5
32. Gamper N., Stockand J.D., and Shapiro M.S. Subunit-specific modulation of KCNQ potassium channels by Src tyrosine kinase. J. Neurosci. 23 (2003) 84-95
33. Matavel A., and Lopes C.M. PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors. J. Mol. Cell. Cardiol. 46 (2009) 704-712
34. + channels. Physiol. Rev. 85 (2005) 33-47
35. Janse M.J. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc. Res. 61 (2004) 208-217
36. Shieh C.C., Coghlan M., Sullivan J.P., and Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol. Rev. 52 (2000) 557-594
37. Tamargo J., Caballero R., Gomez R., Valenzuela C., and Delpon E. Pharmacology of cardiac potassium channels. Cardiovasc. Res. 62 (2004) 9-33
38. Marx S. Ion channel macromolecular complexes in the heart. J. Mol. Cell. Cardiol. 35 (2003) 37-44